Clinical Trial Update: Gut-derived Neuropeptides in Cerebrospinal Fluid of Patients With Parkinson's Disease and Healthy Controls

View source ↗

Summary

A completed clinical trial comparing gut-derived neuropeptides in cerebrospinal fluid between Parkinson's disease patients and healthy controls.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Dr. Marcus Unger | Conditions: Parkinson's Disease | Status: COMPLETED